U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06981845) titled 'Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis' on May 13.
Brief Summary: This study aims to evaluate, through a multicenter, prospective, double-blind, randomized, placebo-controlled clinical trial, whether immunosuppressive therapy improves target lesion-related cardiovascular outcomes compared to placebo treatment in patients with Rapid rEcurrence of Coronary Unexplained in-stent Restenosis (RECUR).
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
In-stent Restenosis Lesion
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atheroscler...